Exchange: NASDAQ·Updated 10:14 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 05

Estimated EPS

-$0.14

Reported EPS

-$0.14

Surprise

-2.44%

Estimated Rev

$39.2M

Reported Rev

$39.01M

Surprise

-0.5%

• Reported GAAP EPS of -$0.14 • Reported revenue of $39.01M down -1.91% YoY • Pacific Biosciences of California, Inc. expects revenue for the full year 2026 to be in the range of $155 million to $165 million, as stated in the 2026 financial outlook.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.13
--
--
N/A
Q2 '26
-$0.14
-$0.14
-2.44%
MISSED
Q1 '26
-$0.14
-$0.03
78.82%
BEAT
Q4 '25
-$0.14
-$0.13
9.53%
BEAT
Q3 '25
-$0.15
-$0.13
14.01%
BEAT

Advertisement|Remove ads.